Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-107353
Filing Date
2021-08-18
Accepted
2021-08-18 16:30:42
Documents
2
Period of Report
2021-08-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2125411-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2125411-1_3seq1.xml 3 1619
2 EXHIBIT 24 tm2125411d1_ex24.htm EX-24 8056
  Complete submission text file 0001104659-21-107353.txt   11091
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Issuer) CIK: 0001442836 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
MISRA TUSHAR (Reporting) CIK: 0001877233 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38129 | Film No.: 211187002